Abstract
Purpose There is limited information on the role of individual- and neighbourhood-level characteristics in explaining the geographic variation in the novel coronavirus 2019 (COVID-19) between regions. This study quantified the magnitude of the variation in COVID-19 rates between neighbourhoods in Ontario, Canada, and examined the extent to which neighbourhood-level differences are explained by census-based neighbourhood measures, after adjusting for individual-level covariates (i.e., age, sex, and chronic conditions).
Methods We conducted a multilevel population-based study of individuals nested within neighbourhoods. COVID-19 laboratory testing data were obtained from a centralized laboratory database and linked to health-administrative data. The median rate ratio and the variance partition coefficient were used to quantify the magnitude of the neighbourhood-level characteristics on the variation of COVID-19 rates.
Results The unadjusted median rate ratio for the between-neighbourhood variation in COVID-19 was 2.22. In the fully adjusted regression models, the individual- and neighbourhood-level covariates accounted for about 44% of the variation in COVID-19 between neighbourhoods, with 43% attributable to neighbourhood-level census-based characteristics.
Conclusion Neighbourhood-level characteristics could explain almost half of the observed geographic variation in COVID-19. Understanding how neighbourhood-level characteristics influence COVID-19 rates can support jurisdictions in creating effective and equitable intervention strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
LCR is funded by a Canada Research Chair in Population Health Analytics (950-230702)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study received ethics approval from the University of Toronto Health Sciences Research Ethics Board. (Protocol #39356)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The dataset from this study is held securely in coded form at ICES. While legal data sharing agreements between ICES and data providers (e.g., healthcare organizations and government) prohibit ICES from making the dataset publicly available, access may be granted to those who meet pre-specified criteria for confidential access, available at www.ices.on.ca/DAS (email: das{at}ices.on.ca)
List of Abbreviations
- CHF
- congestive heart failure
- COPD
- chronic obstructive pulmonary disease
- FSA
- forward sortation area
- ICC
- intraclass correlation coefficient
- IQR
- interquartile range
- LTC
- long-term care
- MRR
- median rate ratio
- OLIS
- Ontario Laboratories Information System database
- PCR
- polymerase chain reaction
- PCV
- proportional change of the variance
- VPC
- variance partition coefficient
